April 8, 2019

Better safety measures are needed for the nation’s blood supply, said two U.S. Food & Drug Administration leaders in a recent statement on the FDA website.

FDA Commissioner Scott Gottlieb and Peter Marks, Director of the FDA Center for Biologics Evaluation and Research, advocated for technology that would kill or inactivate infectious agents in donated whole blood.

“Pathogen reduction technologies can address the infectious risk from viral and bacterial pathogens, enabling us to improve our assurance of safety and reduce the cost of testing,” the statement said.

April 2, 2019

Legally, The Blood & Tissue Center Foundation began on Aug. 19, 2002 when a charter was filed with the state of Texas.

But the origins date to Valentine’s Day, 1993, when a small group of local dignitaries and officials of the South Texas Blood & Tissue Center broke ground on a new facility for the center on Interstate 10. The date was noteworthy because the double hearts had been the organization’s logo for more than 20 years, including its time in the 1920s-era YWCA building in downtown San Antonio.

The new facility opened in 1994 with 80,000 square feet of space that included a state-of-the-art laboratory, donor collection rooms, offices and meeting spaces. It was financed in large part by a tax-exempt bond financed by USAA.

Breaking down acronyms with the experts who work with them day in and day out
March 25, 2019

Karen Leighton, Director of CTRL, helps QualTex Laboratories with overseeing customized testing for customer industries and cellular therapy clients. She answers the question “What is CTRL?”

What is CTRL?

CTRL is the Cell and Tissue Reference Lab and a part of QualTex Laboratories. It is comprised of the Microbiology and Confirmatory labs, with a Cellular Therapy Testing lab in development.

Our multi-purpose lab of 17 employees performs a series of tests that include:

Breaking down acronyms with the experts who work with them day in and day out
March 18, 2019

Scott Jones, Vice President of Scientific Affairs, helps BioBridge Global and its subsidiaries ensure R&D (research and development) develops processes and products that generate business opportunities. He answers the basic question – “What is R&D?”

What is R&D?

The “R” in R&D stands for research, and the “D” stands for development. BBG uses basic and applied research to discover a solution to a problem or create a new product. We perform the appropriate work and processes for the solution or new product. 

Our focus is to take knowledge or technologies from the scientific community and apply them to solve problems or develop new products at BBG. Here at BBG, we perform more development than research, and the form of research we focus on is applied research rather than basic research.

The R&D process involves multiple steps:

March 11, 2019

Tim Blonkvist, architect with Overland Partners, recently visited BioBridge Global and talked with Belinda Flores, Director, Customer Relationship Management in STBTC, about the development of the organization’s art collection.

Overland Partners designed what is now known as the Headquarters Building in 1994.